#BiotechGrowth

Exciting news from the #biopharma sector! Nine biopharma companies have announced record-high revenues for January, indicating a prosperous start to the year.

Among them, Anxo Pharmaceutical Taiwan Co. Ltd (6677.TWO) reported a January revenue of USD 2.74 million, marking a four-year high with a 37% year-on-year growth. Synmosa Biopharma Corporation (4114.TWO) achieved a remarkable revenue of USD 20.82 million, surpassing the USD 17.36 million mark with a 34% month-on-month increase.

Other companies that have announced record-breaking January revenues include 北極星藥業股份有限公司(北極星藥業集團), 東生華製藥股份有限公司TSH Biopharm (8432.TWO), Genetics Generation Advancement Corp (4160.TWO), WILTROM CO. ,LTD (6767.TWO), Johnson Chemical Pharmaceutical Works Co (4747.TWO), G&E herbal biotech
(4911.TWO), and Standard chemical & pharmaceutical company (1720.TWO), setting a solid foundation for growth in the new year.

Read more about these achievements: https://lnkd.in/g4upTQcu

Follow #Globalbio for more updates on the biopharma industry!